AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SPARFLOXACIN

13 registrations across 2 African markets— 9 active

Markets with SPARFLOXACIN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Sparfloxacin Tablets 200 mg_
Tablet
🇳🇬NigeriaLife Vest Global Pharmacy LimitedactiveJun 2030
Sloxin 200 Tablet
Tablet
🇳🇬NigeriaAquatix Pharmaceuticals LimitedactiveSept 2029
Sparfloxacin Tablets 200 mg
Tablet
🇳🇬NigeriaSKYVALLEY PHARMACEUTICALS CO. LTDactiveJul 2029
Gspar 200 Tablets
Tablet
🇳🇬NigeriaGreenlife Pharmaceutical LimitedactiveJan 2028
Zespar 200 Tablet#
Tablet
🇳🇬NigeriaDony-Triumph and Company Nigeria LimitedactiveMay 2026
Tyspart Tablet 200 mg
Tablet
🇳🇬NigeriaSimpec Pharmaceutical LimitedactiveMay 2026
Fortflox 400 Tablets**
Tablet
🇳🇬NigeriaMaydon Pharmaceuticals LimitedactiveMay 2026
Fortflox 200 Tablets**
Tablet
🇳🇬NigeriaMaydon Pharmaceuticals LimitedactiveMar 2026
Sparfon Tablets
Tablet
🇳🇬NigeriaFranphino Pharmaceuticals Nigeria LimitedactiveDec 2025
TALFAX TABLET
TABLETS/2 X 10'S
🇳🇬NigeriaELIONA PHARM. LTDexpiredJul 2022
SPOXIN-200 200MG TABLET
TABLET
🇲🇼MalawiexpiredDec 2004
SPARQUIN 100MG COATED TABLET
COATED TABLET
🇲🇼MalawiexpiredAug 2003
NOVOSPAR 200MG FILM-COATED TABLET
FILM-COATED TABLET
🇲🇼MalawiexpiredFeb 2003

SPARFLOXACIN in Africa — Regulatory Overview

SPARFLOXACIN is registered across 2 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 9 (69%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.